Bevacizumab for NF2‐associated vestibular schwannomas of childhood and adolescence-Reference-Cited by-同舟云学术

Bevacizumab for NF2‐associated vestibular schwannomas of childhood and adolescence

Published:2020-05 Issue:5 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Renzi Samuele¹^ORCID,Michaeli Orli¹²,Salvador Hector³,Alderete Daniel⁴,Ponce Nicolas Fernandez⁴,Zapotocky Michal⁵,Hansford Jordan R.⁶⁷,Malalasekera Vajiranee S.⁶,Toledano Helen²⁸,Maguire Bryan¹,Bouffet Eric¹^ORCID,Ramaswamy Vijay¹⁹^ORCID,Baroni Lorena V.¹⁴^ORCID

Affiliation:

1. Division of Haematology/OncologyHospital for Sick Children Toronto Ontario Canada

2. Division of Haematology/OncologySchneider Medical Center of Israel Petah Tikva Israel

3. Pediatric Oncology DepartmentNeurocutaneous Disorders and Cancer Predisposition UnitSant Joan de Deu Barcelona Spain

4. Service of Hematology/OncologyHospital JP Garrahan Buenos Aires Argentina

5. Department of Paediatric Haematology and OncologySecond Medical SchoolCharles University and University Hospital Motol Prague Czech Republic

6. Children's Cancer CentreRoyal Children's Hospital Melbourne Australia

7. Division of Cancer Murdoch Children's Research Institute Melbourne Australia

8. Sackler Medical SchoolTel Aviv University Tel Aviv Israel

9. Department of Medical Biophysics and PaediatricsUniversity of Toronto Toronto Ontario Canada

Funder

Canadian Institutes of Health Research

Terry Fox Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28228

Reference14 articles.

1. Conference statement. National Institutes of Health Consensus Development Conference;Neurofibromatosis;Arch Neurol,1988

2. National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991

3. Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]

4. An update on the diagnosis and treatment of vestibular schwannoma

5. The role of radiology in the diagnosis and management of vestibular schwannoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review;Journal of Modern Oncology;2024-07-03

2. Brazilian Society of Otology task force – Vestibular Schwannoma ‒ evaluation and treatment;Brazilian Journal of Otorhinolaryngology;2023-11

3. Targeted Therapies in the Treatment of Vestibular Schwannomas: Current State and New Horizons;Otolaryngologic Clinics of North America;2023-06

4. The genetic landscape and possible therapeutics of neurofibromatosis type 2;Cancer Cell International;2023-05-23

5. Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma;Neuro-Oncology;2023-04-03